Phase II study of alternating cytoreductive and cycle-active combination chemotherapy for metastatic breast cancer

C. L. Vogel, N. H. Love, D. R. East, M. R. Moore, R. V. Smalley

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of alternating cytoreductive and cycle-active combination chemotherapy for metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences